MaxCyte, Inc. is a leading biotechnology company based in Rockville, MD, specializing in cell engineering and innovative solutions for biomedical research. With over 20 years of experience, MaxCyte has developed best-in-class electroporation technology that enables efficient and scalable delivery of genetic material into cells, ensuring high cell viability. Their ExPERT instruments, backed by a global team of technical and regulatory experts, empower researchers in the fields of cell gene therapy, discovery, translational research, and bioprocessing to develop transformative treatments and cures for various diseases.
MaxCyte's collaborative approach and cutting-edge technology have supported over 35 clinical trials, facilitating the development of therapies for cancer, heart disease, central nervous system disorders, and rare genetic diseases. Their expertise and commitment to innovation make them a trusted partner for pharmaceutical and biotechnology companies seeking to navigate the complexities of cell engineering and bring new therapeutics to market. MaxCyte's mission is to revolutionize human health by providing researchers with the tools and support they need to advance biomedical innovations and improve patient outcomes.
Generated from the website